Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Effect of the disclosure of MS diagnosis on anxiety, mood and quality of life of patients: a prospective study.
The co-occurrence of multiple sclerosis and type 1 diabetes: Shared aetiologic features and clinical implication for MS aetiology.
Long-term Analyses of Innervation and Neuromuscular Integrity in the Trembler-J Mouse Model of Charcot-Marie-Tooth Disease.
Total-tau in cerebrospinal fluid of patients with multiple sclerosis decreases in secondary progressive stage of disease and reflects degree of brain atrophy.
Consensus statements from a panel of u.s. Managed care pharmacists and physicians for management of multiple sclerosis agents.
Cost analysis of multiple sclerosis in Brazil: a cross-sectional multicenter study.
Sexual Behavior, Body Image, and Partnership in Chronic Illness: A Comparison of Huntington's Disease and Multiple Sclerosis.
Picornavirus infection leading to immunosuppression.
Top 10 Research Questions Related to Physical Activity and Multiple Sclerosis.
Long-term safety and effectiveness of natalizumab redosing and treatment in the STRATA MS Study.
A comparative study of CSF neurofilament light and heavy chain protein in MS.
Peripheral neuropathy associated with mitochondrial disease in children.
Use of Neurofeedback to Enhance Response to Hypnotic Analgesia in Individuals With Multiple Sclerosis.
Dendrimer-based postnatal therapy for neuroinflammation and cerebral palsy in a rabbit model.
Inhibition of Calcineurin Abrogates While Inhibition of mTOR Promotes Regulatory T Cell Expansion and Graft-Versus-Host Disease Protection by IL-2 in Allogeneic Bone Marrow Transplantation.
The impact of multiple sclerosis on family members: a review of the literature.
Analysis of T2 intensity by magnetic resonance imaging of deep gray matter nuclei in multiple sclerosis patients: effect of immunomodulatory therapies.
Compassionate Use Programme Update
Ultra-high-field imaging distinguishes MS lesions from asymptomatic white matter lesions.
Simvastatin inhibits interferon-gamma-induced MHC class II up-regulation in cultured astrocytes.
Papaverine inhibits lipopolysaccharide-induced microglial activation by suppressing NF-κB signaling pathway.
Association between parasite infection and immune responses in multiple sclerosis.
The challenge of multiple sclerosis: how do we cure a chronic heterogeneous disease?
Predictors of freedom from disease activity in natalizumab treated-patients with multiple sclerosis.
The Symptom Inventory Disability-Specific Short Forms for Multiple Sclerosis: Construct Validity, Responsiveness, and Interpretation.
Pages
« first
‹ previous
…
174
175
176
177
178
179
180
181
182
…
next ›
last »